The Chlordiazepoxide and Amitriptyli, cataloged under National Stock Number 6505-01-068-3545, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Hoffmann-La Roche Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-068-3545 |
| Primary Part Number | NDC00140-0071-14 |
| Item Name | Chlordiazepoxide and Amitriptyli |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Hoffmann-La Roche Inc. |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 500.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00140-0071-14 PRIMARY | Hoffmann-La Roche Inc. (USA) |
| Reference | Meaning |
|---|---|
| LIMBITROL 10-25 | 5/1 Secondary reference Hoffmann-La Roche Inc. |
NSN 6505-01-068-3545 is a Chlordiazepoxide and Amitriptyli, manufactured by Hoffmann-La Roche Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-068-3545 has 1 manufacturer part number on file: NDC00140-0071-14 (Hoffmann-La Roche Inc.).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-069-6514. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00140-0071-14: Administration: ORAL; Primary Container Content Quantity: 500.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.